A:

While biotechnology and pharmaceutical companies both produce medicine, biotechnology companies' medicines have a biological basis, and pharmaceutical companies' medicines have a chemical basis. Biotechnology companies use live organisms or their products, such as bacteria or enzymes, to manufacture their drugs. Conversely, pharmaceutical companies use only chemical – and generally artificial – materials to create drugs.

Biotechnology also has more applications than pharmaceutical companies. For example, biotechnology companies have developed versions of crops without specific food allergens, crops that require fewer pesticides and crops with a more complete nutrient profile. While there is some overlap between biotechnology and pharmaceutical companies in terms of research, manufacturing and distributing drugs, biotechnology's scope is much greater.

There is also a substantial difference in operating costs, especially the cost of research and development. Biotechnology companies have much higher costs due to their focus on research and development (as opposed to manufacturing with pharmaceutical companies) and the length of time and difficulty in testing and creating new products.

The discrepancy in the cost and length of time required to manufacture a new product has led to biotechnology products holding their patents for much longer than pharmaceutical companies. Where pharmaceutical companies generally hold the exclusive rights to manufacture and distribute their drugs for five years, biotechnology companies have their patents for 12 years.

All of this leads to very volatile profits for biotechnology companies. Many operate at a loss for many years until a highly profitable substance is manufactured, when their profits can be even greater than pharmaceutical companies. Conversely, pharmaceutical companies' profits, and therefore their stock prices, tend to fluctuate less.

RELATED FAQS
  1. What countries comprise the majority of the global drugs sector?

    Find out which countries are the largest producers of pharmaceutical products in the world and why the United States dominates ... Read Answer >>
  2. What annual return could an investor expect on average from the drug sector?

    Learn which annual average returns the drugs manufacturing sector and its industries can generate for investors based on ... Read Answer >>
  3. Why should an investor include an allocation to the drugs sector in their portfolio?

    Learn why investors should consider allocating assets to the drug sector as part of a diversified investment portfolio and ... Read Answer >>
  4. What percentage of a diversified portfolio should be invested in the drugs sector?

    Learn how to determine how much of a diversified portfolio should be devoted to the pharmaceutical and biotechnology segments ... Read Answer >>
  5. How does the risk of investing in the drugs sector compare to the broader market?

    Learn how the risk of investing in the drugs sector compares to the broader market and what steps investors take to mitigate ... Read Answer >>
  6. What are some popular mutual funds that give exposure to the drugs sector?

    Discover some of the most widely traded and top-rated mutual funds that investors can use to make profits from gains in the ... Read Answer >>
Related Articles
  1. Investing

    IBB: iShares NASDAQ Biotechnology ETF

    Learn about the iShares Nasdaq Biotechnology exchange-traded fund, which offers one of the most diversified ways of investing in the biotechnology sector.
  2. Investing

    Biotech ETF Investors are Still on the Sidelines

    Biotech ETFs are surging, but investors aren't taking the bait. Not yet, at least.
  3. Financial Advisor

    Investing In Biotech: Is It Worth The Risk?

    Investors shunned biotech after a weak start in 2014. Now that a comeback is in the works, should they reconsider?
  4. Investing

    (XBI, FBT, IBB) 3 Bond ETFs in the Biotech Sector

    Learn about the top biotechnology ETFs, such as the SPDR S&P Biotech ETF, the First Trust NYSE Arca Biotech ETF and the iShares Nasdaq Biotech ETF.
  5. Investing

    UBIO: ProShares UltraPro Nasdaq Biotech ETF

    Obtain information about an ETF offerings that provides leveraged exposure to the biotechnology industry, the ProShares UltraPro Nasdaq Biotech Fund.
  6. Investing

    Are Bears About to Burst the Biotech Bubble? (IBB, BIB)

    The recent biotech rally has richly rewarded many investors. So will the fortunes be soon swept away?
  7. Investing

    Key Financial Ratios to Analyze Biotech Companies (AMGN, GILD)

    Explore the rapidly growing biotechnology industry, and learn some of the key financial ratios investors use to analyze companies in the industry.
  8. Investing

    Active Traders Turn Bullish on Biotech

    The recent price activity of two key ETFs suggests that the biotech sector is poised for a comeback.
  9. Investing

    The Top 5 Small-Cap Biotechnology Stocks for 2016

    Discover the top five small-cap biotechnology stocks for 2016, with a summary, growth outlook and expected price target for the next year.
  10. Investing

    3 Volatile U.S. Industries to Exploit in 2016 (VRX, IBB)

    Read about volatile sectors in the stock market that may provide opportunities for investors in 2016, including energy, mining and biotechnology.
RELATED TERMS
  1. Pharmaceutical Industry ETF

    A sector-following fund that invests in developers and manufacturers ...
  2. Intellectual Property Rights (Biotechnology)

    In health care, intellectual property rights give their owners ...
  3. Medical Patent

    A legal protection against market competition that a government ...
  4. Orphan Drug Credit

    A federal tax credit that provides an incentive for pharmaceutical ...
  5. Healthcare Sector

    A category of stocks relating to medical and healthcare goods ...
  6. Food And Drug Administration - FDA

    A government agency established in 1906 with the passage of the ...
Hot Definitions
  1. Investing

    The act of committing money or capital to an endeavor with the expectation of obtaining an additional income or profit.
  2. Stagflation

    A condition of slow economic growth and relatively high unemployment - a time of stagnation - accompanied by a rise in prices, ...
  3. Notional Value

    The total value of a leveraged position's assets. This term is commonly used in the options, futures and currency markets ...
  4. Interest Expense

    The cost incurred by an entity for borrowed funds. Interest expense is a non-operating expense shown on the income statement. ...
  5. Call Option

    An agreement that gives an investor the right (but not the obligation) to buy a stock, bond, commodity, or other instrument ...
  6. Pro-Rata

    Used to describe a proportionate allocation. A method of assigning an amount to a fraction, according to its share of the ...
Trading Center